Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Service & Software > Clinical Pathology AI Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Clinical Pathology AI Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published: 2026-01-09

Pages: 122 Pages

Report ld: 5646695

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Clinical Pathology AI Software was estimated to be worth US$ 251 million in 2025 and is projected to reach US$ 477 million, growing at a CAGR of 9.8% from 2026 to 2032.

Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.

Clinical Pathology AI Software Market Size(US$)

M= millions and B=billions

The North American market for Clinical Pathology AI Software was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Clinical Pathology AI Software was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Clinical Pathology AI Software was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Clinical Pathology AI Software market include PathAI, Proscia, Aiforia, Deep Bio, Hologic, Dipath, iDeepwise, LBP, F.Q pathtech, CellaVision, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Clinical Pathology AI Software, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Clinical Pathology AI Software market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Clinical Pathology AI Software.

Market Segmentation

Report Metric
Details
Report Title
Clinical Pathology AI Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 477 million
CAGR(2026-2032)
9.8%
Market Size Available for Years
2026-2032
Global Clinical Pathology AI Software Companies Covered
PathAI
Proscia
Aiforia
Deep Bio
Hologic
Dipath
iDeepwise
LBP
F.Q pathtech
CellaVision
AIRA Matrix
Syntropy
Indica Labs
DoMore Diagnostics
Mindpeak
Evidium
Global Clinical Pathology AI Software Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Pathology AI Software Market, Segment by Type
Cloud-Based
On-Premise
Global Clinical Pathology AI Software Market, Segment by Application
Hospital
Diagnostic Centers
Laboratories & Research Institutes
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Clinical Pathology AI Software companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Clinical Pathology AI Software revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Clinical Pathology AI Software revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Clinical Pathology AI Software Product Introduction
    1.2 Global Clinical Pathology AI Software Market Size Forecast (2021–2032)
    1.3 Clinical Pathology AI Software Market Trends & Drivers
        1.3.1 Clinical Pathology AI Software Industry Trends
        1.3.2 Clinical Pathology AI Software Market Drivers & Opportunities
        1.3.3 Clinical Pathology AI Software Market Challenges
        1.3.4 Clinical Pathology AI Software Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Clinical Pathology AI Software Players Revenue Ranking (2025)
    2.2 Global Clinical Pathology AI Software Revenue by Company (2021–2026)
    2.3 Key Companies’ R&D and Operations Footprint and Headquarters
    2.4 Key Companies Clinical Pathology AI Software Product Offerings
    2.5 Key Companies General Availability (GA) Timeline for Clinical Pathology AI Software
    2.6 Clinical Pathology AI Software Market Competitive Analysis
        2.6.1 Clinical Pathology AI Software Market Concentration Rate (2021–2026)
        2.6.2 Top 5 and Top 10 Global Companies by Clinical Pathology AI Software Revenue in 2025
        2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Clinical Pathology AI Software revenue, 2025
    2.7 Mergers & Acquisitions and Expansion

3 Segmentation Clinical Pathology AI Software Market Classification
    3.1 Introduction by Type
        3.1.1 Cloud-Based
        3.1.2 On-Premise
        3.1.3 Global Clinical Pathology AI Software Sales Value by Type
            3.1.3.1 Global Clinical Pathology AI Software Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.3.2 Global Clinical Pathology AI Software Sales Value, by Type (2021–2032)
            3.1.3.3 Global Clinical Pathology AI Software Sales Value, by Type (%), 2021–2032

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Diagnostic Centers
        4.1.3 Laboratories & Research Institutes
    4.2 Global Clinical Pathology AI Software Sales Value by Application
        4.2.1 Global Clinical Pathology AI Software Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Clinical Pathology AI Software Sales Value by Application (2021–2032)
        4.2.3 Global Clinical Pathology AI Software Sales Value by Application (%), 2021–2032

5 Segmentation by Region
    5.1 Global Clinical Pathology AI Software Sales Value by Region
        5.1.1 Global Clinical Pathology AI Software Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Clinical Pathology AI Software Sales Value by Region (2021–2026)
        5.1.3 Global Clinical Pathology AI Software Sales Value by Region (2027–2032)
        5.1.4 Global Clinical Pathology AI Software Sales Value by Region (%), 2021–2032
    5.2 North America
        5.2.1 North America Clinical Pathology AI Software Sales Value, 2021–2032
        5.2.2 North America Clinical Pathology AI Software Sales Value by Country (%), 2025 vs 2032
    5.3 Europe
        5.3.1 Europe Clinical Pathology AI Software Sales Value, 2021–2032
        5.3.2 Europe Clinical Pathology AI Software Sales Value by Country (%), 2025 vs 2032
    5.4 Asia Pacific
        5.4.1 Asia Pacific Clinical Pathology AI Software Sales Value, 2021–2032
        5.4.2 Asia Pacific Clinical Pathology AI Software Sales Value by Subregion (%), 2025 vs 2032
    5.5 South America
        5.5.1 South America Clinical Pathology AI Software Sales Value, 2021–2032
        5.5.2 South America Clinical Pathology AI Software Sales Value by Country (%), 2025 vs 2032
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Clinical Pathology AI Software Sales Value, 2021–2032
        5.6.2 Middle East & Africa Clinical Pathology AI Software Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Clinical Pathology AI Software Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Clinical Pathology AI Software Sales Value, 2021–2032
    6.3 United States
        6.3.1 United States Clinical Pathology AI Software Sales Value, 2021–2032
        6.3.2 United States Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Clinical Pathology AI Software Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Clinical Pathology AI Software Sales Value, 2021–2032
        6.4.2 Europe Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Clinical Pathology AI Software Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Clinical Pathology AI Software Sales Value, 2021–2032
        6.5.2 China Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Clinical Pathology AI Software Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Clinical Pathology AI Software Sales Value, 2021–2032
        6.6.2 Japan Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Clinical Pathology AI Software Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Clinical Pathology AI Software Sales Value, 2021–2032
        6.7.2 South Korea Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Clinical Pathology AI Software Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Clinical Pathology AI Software Sales Value, 2021–2032
        6.8.2 Southeast Asia Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Clinical Pathology AI Software Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Clinical Pathology AI Software Sales Value, 2021–2032
        6.9.2 India Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Clinical Pathology AI Software Sales Value by Application, 2025 vs 2032

7 Company Profiles
    7.1 PathAI
        7.1.1 PathAI Profile
        7.1.2 PathAI Main Business
        7.1.3 PathAI Clinical Pathology AI Software Products, Services, and Solutions
        7.1.4 PathAI Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.1.5 PathAI Recent Developments
    7.2 Proscia
        7.2.1 Proscia Profile
        7.2.2 Proscia Main Business
        7.2.3 Proscia Clinical Pathology AI Software Products, Services, and Solutions
        7.2.4 Proscia Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.2.5 Proscia Recent Developments
    7.3 Aiforia
        7.3.1 Aiforia Profile
        7.3.2 Aiforia Main Business
        7.3.3 Aiforia Clinical Pathology AI Software Products, Services, and Solutions
        7.3.4 Aiforia Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.3.5 Aiforia Recent Developments
    7.4 Deep Bio
        7.4.1 Deep Bio Profile
        7.4.2 Deep Bio Main Business
        7.4.3 Deep Bio Clinical Pathology AI Software Products, Services, and Solutions
        7.4.4 Deep Bio Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.4.5 Deep Bio Recent Developments
    7.5 Hologic
        7.5.1 Hologic Profile
        7.5.2 Hologic Main Business
        7.5.3 Hologic Clinical Pathology AI Software Products, Services, and Solutions
        7.5.4 Hologic Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.5.5 Hologic Recent Developments
    7.6 Dipath
        7.6.1 Dipath Profile
        7.6.2 Dipath Main Business
        7.6.3 Dipath Clinical Pathology AI Software Products, Services, and Solutions
        7.6.4 Dipath Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.6.5 Dipath Recent Developments
    7.7 iDeepwise
        7.7.1 iDeepwise Profile
        7.7.2 iDeepwise Main Business
        7.7.3 iDeepwise Clinical Pathology AI Software Products, Services, and Solutions
        7.7.4 iDeepwise Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.7.5 iDeepwise Recent Developments
    7.8 LBP
        7.8.1 LBP Profile
        7.8.2 LBP Main Business
        7.8.3 LBP Clinical Pathology AI Software Products, Services, and Solutions
        7.8.4 LBP Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.8.5 LBP Recent Developments
    7.9 F.Q pathtech
        7.9.1 F.Q pathtech Profile
        7.9.2 F.Q pathtech Main Business
        7.9.3 F.Q pathtech Clinical Pathology AI Software Products, Services, and Solutions
        7.9.4 F.Q pathtech Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.9.5 F.Q pathtech Recent Developments
    7.10 CellaVision
        7.10.1 CellaVision Profile
        7.10.2 CellaVision Main Business
        7.10.3 CellaVision Clinical Pathology AI Software Products, Services, and Solutions
        7.10.4 CellaVision Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.10.5 CellaVision Recent Developments
    7.11 AIRA Matrix
        7.11.1 AIRA Matrix Profile
        7.11.2 AIRA Matrix Main Business
        7.11.3 AIRA Matrix Clinical Pathology AI Software Products, Services, and Solutions
        7.11.4 AIRA Matrix Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.11.5 AIRA Matrix Recent Developments
    7.12 Syntropy
        7.12.1 Syntropy Profile
        7.12.2 Syntropy Main Business
        7.12.3 Syntropy Clinical Pathology AI Software Products, Services, and Solutions
        7.12.4 Syntropy Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.12.5 Syntropy Recent Developments
    7.13 Indica Labs
        7.13.1 Indica Labs Profile
        7.13.2 Indica Labs Main Business
        7.13.3 Indica Labs Clinical Pathology AI Software Products, Services, and Solutions
        7.13.4 Indica Labs Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.13.5 Indica Labs Recent Developments
    7.14 DoMore Diagnostics
        7.14.1 DoMore Diagnostics Profile
        7.14.2 DoMore Diagnostics Main Business
        7.14.3 DoMore Diagnostics Clinical Pathology AI Software Products, Services, and Solutions
        7.14.4 DoMore Diagnostics Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.14.5 DoMore Diagnostics Recent Developments
    7.15 Mindpeak
        7.15.1 Mindpeak Profile
        7.15.2 Mindpeak Main Business
        7.15.3 Mindpeak Clinical Pathology AI Software Products, Services, and Solutions
        7.15.4 Mindpeak Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.15.5 Mindpeak Recent Developments
    7.16 Evidium
        7.16.1 Evidium Profile
        7.16.2 Evidium Main Business
        7.16.3 Evidium Clinical Pathology AI Software Products, Services, and Solutions
        7.16.4 Evidium Clinical Pathology AI Software Revenue (US$ Million), 2021–2026
        7.16.5 Evidium Recent Developments

8 Industry Chain Analysis
    8.1 Clinical Pathology AI Software Value Chain
    8.2 Clinical Pathology AI Software Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream (Customer) Analysis
    8.5 Sales Model and Sales Channelss
        8.5.1 Clinical Pathology AI Software Sales Model
        8.5.2 Sales Channels
        8.5.3 Clinical Pathology AI Software Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Clinical Pathology AI Software Market Trends
 Table 2. Clinical Pathology AI Software Market Drivers & Opportunities
 Table 3. Clinical Pathology AI Software Market Challenges
 Table 4. Clinical Pathology AI Software Market Restraints
 Table 5. Global Clinical Pathology AI Software Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Clinical Pathology AI Software Revenue Market Share by Company (2021–2026)
 Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
 Table 8. Key Companies Clinical Pathology AI Software Product Type
 Table 9. Key Companies General Availability (GA) Timeline for Clinical Pathology AI Software
 Table 10. Global Clinical Pathology AI Software Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Clinical Pathology AI Software revenue, 2025
 Table 12. Mergers & Acquisitions and Expansion Plans
 Table 13. Global Clinical Pathology AI Software Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 14. Global Clinical Pathology AI Software Sales Value by Type (US$ Million), 2021–2026
 Table 15. Global Clinical Pathology AI Software Sales Value by Type (US$ Million), 2027–2032
 Table 16. Global Clinical Pathology AI Software Sales Market Share in Value by Type (2021–2026)
 Table 17. Global Clinical Pathology AI Software Sales Market Share in Value by Type (2027–2032)
 Table 18. Global Clinical Pathology AI Software Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 19. Global Clinical Pathology AI Software Sales Value by Application (US$ Million), 2021–2026
 Table 20. Global Clinical Pathology AI Software Sales Value by Application (US$ Million), 2027–2032
 Table 21. Global Clinical Pathology AI Software Sales Market Share in Value by Application (2021–2026)
 Table 22. Global Clinical Pathology AI Software Sales Market Share in Value by Application (2027–2032)
 Table 23. Global Clinical Pathology AI Software Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 24. Global Clinical Pathology AI Software Sales Value by Region (US$ Million), 2021–2026
 Table 25. Global Clinical Pathology AI Software Sales Value by Region (US$ Million), 2027–2032
 Table 26. Global Clinical Pathology AI Software Sales Value by Region (%), 2021–2026
 Table 27. Global Clinical Pathology AI Software Sales Value by Region (%), 2027–2032
 Table 28. Key Countries/Regions Clinical Pathology AI Software Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 29. Key Countries/Regions Clinical Pathology AI Software Sales Value, (US$ Million), 2021–2026
 Table 30. Key Countries/Regions Clinical Pathology AI Software Sales Value, (US$ Million), 2027–2032
 Table 31. PathAI Basic Information List
 Table 32. PathAI Description and Business Overview
 Table 33. PathAI Clinical Pathology AI Software Products, Services, and Solutions
 Table 34. Revenue (US$ Million) in Clinical Pathology AI Software Business of PathAI (2021–2026)
 Table 35. PathAI Recent Developments
 Table 36. Proscia Basic Information List
 Table 37. Proscia Description and Business Overview
 Table 38. Proscia Clinical Pathology AI Software Products, Services, and Solutions
 Table 39. Revenue (US$ Million) in Clinical Pathology AI Software Business of Proscia (2021–2026)
 Table 40. Proscia Recent Developments
 Table 41. Aiforia Basic Information List
 Table 42. Aiforia Description and Business Overview
 Table 43. Aiforia Clinical Pathology AI Software Products, Services, and Solutions
 Table 44. Revenue (US$ Million) in Clinical Pathology AI Software Business of Aiforia (2021–2026)
 Table 45. Aiforia Recent Developments
 Table 46. Deep Bio Basic Information List
 Table 47. Deep Bio Description and Business Overview
 Table 48. Deep Bio Clinical Pathology AI Software Products, Services, and Solutions
 Table 49. Revenue (US$ Million) in Clinical Pathology AI Software Business of Deep Bio (2021–2026)
 Table 50. Deep Bio Recent Developments
 Table 51. Hologic Basic Information List
 Table 52. Hologic Description and Business Overview
 Table 53. Hologic Clinical Pathology AI Software Products, Services, and Solutions
 Table 54. Revenue (US$ Million) in Clinical Pathology AI Software Business of Hologic (2021–2026)
 Table 55. Hologic Recent Developments
 Table 56. Dipath Basic Information List
 Table 57. Dipath Description and Business Overview
 Table 58. Dipath Clinical Pathology AI Software Products, Services, and Solutions
 Table 59. Revenue (US$ Million) in Clinical Pathology AI Software Business of Dipath (2021–2026)
 Table 60. Dipath Recent Developments
 Table 61. iDeepwise Basic Information List
 Table 62. iDeepwise Description and Business Overview
 Table 63. iDeepwise Clinical Pathology AI Software Products, Services, and Solutions
 Table 64. Revenue (US$ Million) in Clinical Pathology AI Software Business of iDeepwise (2021–2026)
 Table 65. iDeepwise Recent Developments
 Table 66. LBP Basic Information List
 Table 67. LBP Description and Business Overview
 Table 68. LBP Clinical Pathology AI Software Products, Services, and Solutions
 Table 69. Revenue (US$ Million) in Clinical Pathology AI Software Business of LBP (2021–2026)
 Table 70. LBP Recent Developments
 Table 71. F.Q pathtech Basic Information List
 Table 72. F.Q pathtech Description and Business Overview
 Table 73. F.Q pathtech Clinical Pathology AI Software Products, Services, and Solutions
 Table 74. Revenue (US$ Million) in Clinical Pathology AI Software Business of F.Q pathtech (2021–2026)
 Table 75. F.Q pathtech Recent Developments
 Table 76. CellaVision Basic Information List
 Table 77. CellaVision Description and Business Overview
 Table 78. CellaVision Clinical Pathology AI Software Products, Services, and Solutions
 Table 79. Revenue (US$ Million) in Clinical Pathology AI Software Business of CellaVision (2021–2026)
 Table 80. CellaVision Recent Developments
 Table 81. AIRA Matrix Basic Information List
 Table 82. AIRA Matrix Description and Business Overview
 Table 83. AIRA Matrix Clinical Pathology AI Software Products, Services, and Solutions
 Table 84. Revenue (US$ Million) in Clinical Pathology AI Software Business of AIRA Matrix (2021–2026)
 Table 85. AIRA Matrix Recent Developments
 Table 86. Syntropy Basic Information List
 Table 87. Syntropy Description and Business Overview
 Table 88. Syntropy Clinical Pathology AI Software Products, Services, and Solutions
 Table 89. Revenue (US$ Million) in Clinical Pathology AI Software Business of Syntropy (2021–2026)
 Table 90. Syntropy Recent Developments
 Table 91. Indica Labs Basic Information List
 Table 92. Indica Labs Description and Business Overview
 Table 93. Indica Labs Clinical Pathology AI Software Products, Services, and Solutions
 Table 94. Revenue (US$ Million) in Clinical Pathology AI Software Business of Indica Labs (2021–2026)
 Table 95. Indica Labs Recent Developments
 Table 96. DoMore Diagnostics Basic Information List
 Table 97. DoMore Diagnostics Description and Business Overview
 Table 98. DoMore Diagnostics Clinical Pathology AI Software Products, Services, and Solutions
 Table 99. Revenue (US$ Million) in Clinical Pathology AI Software Business of DoMore Diagnostics (2021–2026)
 Table 100. DoMore Diagnostics Recent Developments
 Table 101. Mindpeak Basic Information List
 Table 102. Mindpeak Description and Business Overview
 Table 103. Mindpeak Clinical Pathology AI Software Products, Services, and Solutions
 Table 104. Revenue (US$ Million) in Clinical Pathology AI Software Business of Mindpeak (2021–2026)
 Table 105. Mindpeak Recent Developments
 Table 106. Evidium Basic Information List
 Table 107. Evidium Description and Business Overview
 Table 108. Evidium Clinical Pathology AI Software Products, Services, and Solutions
 Table 109. Revenue (US$ Million) in Clinical Pathology AI Software Business of Evidium (2021–2026)
 Table 110. Evidium Recent Developments
 Table 111. Revenue (US$ Million) in Clinical Pathology AI Software Business of Company 40 (2021–2026)
 Table 112. Company 40 Recent Developments
 Table 113. Key Raw Materials Lists
 Table 114. Key Suppliers of Raw Materials Lists
 Table 115. Clinical Pathology AI Software Downstream Customers
 Table 116. Clinical Pathology AI Software Distributors List
 Table 117. Research Programs/Design for This Report
 Table 118. Key Data Information from Secondary Sources
 Table 119. Key Data Information from Primary Sources


List of Figures
 Figure 1. Clinical Pathology AI Software Product Picture
 Figure 2. Global Clinical Pathology AI Software Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 4. Clinical Pathology AI Software Report Years Considered
 Figure 5. Global Clinical Pathology AI Software Players Revenue Ranking (US$ Million), 2025
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Pathology AI Software Revenue in 2025
 Figure 7. Clinical Pathology AI Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 8. Cloud-Based Picture
 Figure 9. On-Premise Picture
 Figure 10. Global Clinical Pathology AI Software Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Clinical Pathology AI Software Sales Value Market Share by Type, 2025 & 2032
 Figure 12. Product Picture of Hospital
 Figure 13. Product Picture of Diagnostic Centers
 Figure 14. Product Picture of Laboratories & Research Institutes
 Figure 15. Global Clinical Pathology AI Software Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Clinical Pathology AI Software Sales Value Market Share by Application, 2025 & 2032
 Figure 17. North America Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 18. North America Clinical Pathology AI Software Sales Value by Country (%), 2025 vs 2032
 Figure 19. Europe Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 20. Europe Clinical Pathology AI Software Sales Value by Country (%), 2025 vs 2032
 Figure 21. Asia Pacific Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 22. Asia Pacific Clinical Pathology AI Software Sales Value by Subregion (%), 2025 vs 2032
 Figure 23. South America Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 24. South America Clinical Pathology AI Software Sales Value by Country (%), 2025 vs 2032
 Figure 25. Middle East & Africa Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 26. Middle East & Africa Clinical Pathology AI Software Sales Value by Country (%), 2025 vs 2032
 Figure 27. Key Countries/Regions Clinical Pathology AI Software Sales Value (%), 2021–2032
 Figure 28. United States Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 29. United States Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
 Figure 30. United States Clinical Pathology AI Software Sales Value by Application (%), 2025 vs 2032
 Figure 31. Europe Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 32. Europe Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
 Figure 33. Europe Clinical Pathology AI Software Sales Value by Application (%), 2025 vs 2032
 Figure 34. China Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 35. China Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
 Figure 36. China Clinical Pathology AI Software Sales Value by Application (%), 2025 vs 2032
 Figure 37. Japan Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 38. Japan Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
 Figure 39. Japan Clinical Pathology AI Software Sales Value by Application (%), 2025 vs 2032
 Figure 40. South Korea Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 41. South Korea Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
 Figure 42. South Korea Clinical Pathology AI Software Sales Value by Application (%), 2025 vs 2032
 Figure 43. Southeast Asia Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 44. Southeast Asia Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
 Figure 45. Southeast Asia Clinical Pathology AI Software Sales Value by Application (%), 2025 vs 2032
 Figure 46. India Clinical Pathology AI Software Sales Value (US$ Million), 2021–2032
 Figure 47. India Clinical Pathology AI Software Sales Value by Type (%), 2025 vs 2032
 Figure 48. India Clinical Pathology AI Software Sales Value by Application (%), 2025 vs 2032
 Figure 49. Clinical Pathology AI Software Value Chain
 Figure 50. Clinical Pathology AI Software Cost Structure
 Figure 51. Channels of Distribution (Direct Sales, and Distribution)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed

Description

The global market for Clinical Pathology AI Software was estimated to be worth US$ 251 million in 2025 and is projected to reach US$ 477 million, growing at a CAGR of 9.8% from 2026 to 2032.

Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.

The North American market for Clinical Pathology AI Software was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Clinical Pathology AI Software was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Clinical Pathology AI Software was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Clinical Pathology AI Software companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Clinical Pathology AI Software revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Clinical Pathology AI Software revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Global Clinical Pathology AI Software Market Insights, Forecast to 2030
Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.
Published: 2024-09-06
Pages: 148
USD 4900.00
(Single User License)
Global and United States Clinical Pathology AI Software Market Report & Forecast 2024-2030
Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.
Published: 2024-09-06
Pages: 122
USD 4350.00
(Single User License)
Global Clinical Pathology AI Software Market Research Report 2024
Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.
Published: 2024-09-06
Pages: 100
USD 2900.00
(Single User License)
Global Clinical Pathology AI Software Market Research Report 2025
The global market for Clinical Pathology AI Software was valued at US$ 231 million in the year 2024 and is projected to reach a revised size of US$ 438 million by 2031, growing at a CAGR of 9.8% during the forecast period.
Published: 2025-03-12
Pages: 96
USD 2900.00
(Single User License)
Clinical Pathology AI Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Pathology AI Software was estimated to be worth US$ 231 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 138
USD 3950.00
(Single User License)
Global Clinical Pathology AI Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Clinical Pathology AI Software market is projected to grow from US$ 231 million in 2024 to US$ 438 million by 2031, at a CAGR of 9.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 146
USD 4900.00
(Single User License)
Global Clinical Pathology AI Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Clinical Pathology AI Software market size was US$ 231 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 109
USD 4250.00
(Single User License)
Global Clinical Pathology AI Software Market Research Report 2026
The global Clinical Pathology AI Software market was valued at US$ 251 million in 2025 and is anticipated to reach US$ 477 million by 2032, at a CAGR of 9.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 132
USD 2900.00
(Single User License)
Global Clinical Pathology AI Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Clinical Pathology AI Software market size was US$ 251 million in 2025 and is forecast to reach a readjusted size of US$ 477 million by 2032 with a CAGR of 9.8% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 104
USD 4250.00
(Single User License)
Global Clinical Pathology AI Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Clinical Pathology AI Software market is projected to grow from US$ 251 million in 2025 to US$ 477 million by 2032, at a CAGR of 9.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 150
USD 4900.00
(Single User License)

Global Clinical Pathology AI Software Market Insights, Forecast to 2030
Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.
Published: 2024-09-06
Pages: 148
USD 4900.00 ()
Global and United States Clinical Pathology AI Software Market Report & Forecast 2024-2030
Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.
Published: 2024-09-06
Pages: 122
USD 4350.00 ()
Global Clinical Pathology AI Software Market Research Report 2024
Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.
Published: 2024-09-06
Pages: 100
USD 2900.00 ()
Global Clinical Pathology AI Software Market Research Report 2025
The global market for Clinical Pathology AI Software was valued at US$ 231 million in the year 2024 and is projected to reach a revised size of US$ 438 million by 2031, growing at a CAGR of 9.8% during the forecast period.
Published: 2025-03-12
Pages: 96
USD 2900.00 ()
Clinical Pathology AI Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Pathology AI Software was estimated to be worth US$ 231 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 138
USD 3950.00 ()
Global Clinical Pathology AI Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Clinical Pathology AI Software market is projected to grow from US$ 231 million in 2024 to US$ 438 million by 2031, at a CAGR of 9.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 146
USD 4900.00 ()
Global Clinical Pathology AI Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Clinical Pathology AI Software market size was US$ 231 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 109
USD 4250.00 ()
Global Clinical Pathology AI Software Market Research Report 2026
The global Clinical Pathology AI Software market was valued at US$ 251 million in 2025 and is anticipated to reach US$ 477 million by 2032, at a CAGR of 9.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 132
USD 2900.00 ()
Global Clinical Pathology AI Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Clinical Pathology AI Software market size was US$ 251 million in 2025 and is forecast to reach a readjusted size of US$ 477 million by 2032 with a CAGR of 9.8% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 104
USD 4250.00 ()
Global Clinical Pathology AI Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Clinical Pathology AI Software market is projected to grow from US$ 251 million in 2025 to US$ 477 million by 2032, at a CAGR of 9.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 150
USD 4900.00 ()